Can Wegovy or Ozempic Make You Fail a Breathalyzer? Ketones, Ignition Interlocks, and False Positives
A November 2026 case report describes a woman with years of sobriety who failed two ignition interlock breath tests days after raising her Wegovy dose. Eating much less can push the body to make a compound that some breath alcohol devices read as alcohol. The evidence is thin, but drivers with interlocks should know how it could happen and what to do.
Key points
- A November 2026 case report in the Medico-Legal Journal describes a 45-year-old woman with several years of sobriety who had two positive ignition interlock results within days of raising her Wegovy dose from 1.0 mg to 1.7 mg; the author proposes reduced eating led to acetone that the body converted to isopropanol
- Ignition interlocks use fuel-cell sensors, which do not react to acetone but do react to other alcohols such as isopropanol, as Jones and Rössner explained in a 2007 report of a teetotaler on a very low-calorie diet whose interlock-equipped car would not start
- NHTSA's 2013 model specifications require interlocks to pass an acetone interference test but include no isopropanol test, and they describe a lockout point of 0.02 g/dL
- No study has measured breath alcohol readings or mild ketosis in GLP-1 users; published evidence of GLP-1-related ketosis comes from case reports of starvation ketoacidosis with tirzepatide and oral semaglutide and from FDA adverse event reports
- A blood test taken soon after a disputed reading can measure ethanol, acetone, and isopropanol separately, which is how investigators cleared a Swedish driver in a 1995 case
The short answer
Possibly, in rare cases, and mainly with the fuel-cell breath testers used in ignition interlocks. No study has measured breath alcohol readings in people taking GLP-1 drugs. What exists is one case report from November 2026 plus older reports of false positives in people on very low-calorie diets or with ketoacidosis, a dangerous buildup of acids called ketones.
The proposed chain works like this. When you eat far less than usual, your body burns more fat and makes ketones, including acetone. The liver can turn some acetone into isopropanol, also called isopropyl alcohol. Fuel-cell sensors detect alcohols by a chemical reaction, and they react to isopropanol as well as to ethanol, the alcohol in drinks.
If you drive with an ignition interlock and take semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), the practical steps are to keep eating enough, keep records of your doses, and know how to get a blood test quickly if a reading is wrong. Those steps are covered below.
The Minnesota case
On November 12, 2026, the Medico-Legal Journal published a case report by Aaron Olson of ARO Consulting in Hugo, Minnesota. It describes a 45-year-old woman prescribed Wegovy who had two positive ignition interlock results within days of increasing her dose from 1.0 mg to 1.7 mg a week. On the standard Wegovy schedule, 1.7 mg is the fourth step, usually started in week 13, before the 2.4 mg maintenance dose.
The woman denied drinking, testified that she had been sober for several years, and had otherwise kept her job and complied with her interlock requirements. The report proposes that eating less after the dose increase made her body rely more on fat for fuel, raising her acetone, some of which was converted to isopropanol. The author concludes that this mechanism "should be considered when evaluating disputed ignition interlock violations" in people using GLP-1 drugs.
A case report shows that something is possible, not how often it happens. The published abstract does not report blood ketone or isopropanol measurements from the time of the tests, so the explanation remains a proposed one.
How dieting can produce a breath "alcohol"
Ketones are fuels the liver makes from fat when the body is short on carbohydrates. They include beta-hydroxybutyrate, acetoacetate, and acetone. Acetone is what gives some people on strict diets, or people with diabetic ketoacidosis, a fruity breath smell.
The key step is that liver enzymes called alcohol dehydrogenases can convert acetone into isopropanol. In a 1995 Swedish case, Wayne Jones and Lars Andersson found acetone and isopropanol, but no ethanol, in the blood of a driver stopped at a sobriety checkpoint who was on a special diet for high blood sugar. His roadside screening test with an electrochemical device was positive.
In 2007, Jones and the Swedish obesity specialist Stephan Rössner reported a 59-year-old man on a very low-calorie diet whose car, fitted with an alcohol ignition interlock, would not start. He did not drink at all. The authors explained that the interlock's sensor does not react to acetone itself but does react to other alcohols, including isopropanol, which the man's body had made from acetone. They wrote that this "side effect" of ketogenic diets deserved attention for people in safety-sensitive jobs who face random breath tests.
In 2019, a Navy physician described a 37-year-old sailor with no known diabetes whose elevated reading on a routine duty breath test led doctors to find diabetic ketoacidosis before he had any symptoms.
Why interlocks are more exposed than police breath tests
Breath testers use two main technologies.
- Fuel cells, used in ignition interlocks and many handheld screeners, measure alcohol through electrochemical oxidation. They largely ignore acetone but respond to other alcohols such as isopropanol and methanol.
- Infrared analyzers, used for many evidential tests at police stations, measure how breath absorbs light. Older single-wavelength models could respond to acetone. In a 1987 study, Jones had six healthy men fast for 12 and 36 hours. After 36 hours, breath acetone rose sharply, but the highest apparent alcohol reading was 0.005 g/210 L, too small to matter for evidential testing. In the 1995 Swedish case, a dual-wavelength infrared instrument flagged an interfering substance in the driver's breath.
The U.S. National Highway Traffic Safety Administration's model specifications for breath alcohol ignition interlocks, last revised in May 2013, include an acetone test: a device must still let the car start when a test sample contains a set amount of acetone. NHTSA called acetone "the most common interfering substance" for these devices. The specifications do not include a matching test for isopropanol, which fuel cells are built to detect as an alcohol.
The same specifications describe devices that lock out the engine at a breath alcohol level of 0.02 g/dL, a quarter of the 0.08 legal driving limit in most states. A small amount of isopropanol could matter more at that threshold than it would at a roadside 0.08 test.
Can GLP-1 drugs push the body into ketosis?
GLP-1 drugs reduce appetite and slow how fast the stomach empties, and many people eat much less, especially after a dose increase. Nausea and vomiting are common side effects. Eating very little for days is the same situation that produced false positives in the diet cases above.
No published study has measured how often people on semaglutide or tirzepatide develop mild ketosis, the level that might matter for a breath test. The literature shows only the severe end, starvation ketoacidosis, in case reports:
- A 30-year-old woman in Saudi Arabia with a normal BMI and no diabetes developed euglycemic ketoacidosis, meaning ketoacidosis with normal blood sugar, after raising unprescribed tirzepatide from 2.5 mg to 5 mg. She had four days of severe vomiting and needed intensive care (American Journal of Case Reports, 2026).
- A woman in her early 30s in the United Arab Emirates developed ketoacidosis six days after her first tirzepatide injection (Cureus, 2026).
- A young woman with a normal BMI developed starvation ketoacidosis after five days of oral semaglutide prescribed for weight loss (Journal of International Medical Research, 2026).
An analysis of the FDA's adverse event reporting system from 2021 through 2025 found 261 ketoacidosis reports with semaglutide and 209 with tirzepatide among people without diabetes, with a stronger reporting signal for semaglutide. Reports like these cannot show how common the problem is, because most cases are never reported and the number of people taking each drug is not known from the database.
The risk of ketosis is higher when GLP-1 drugs are combined with a low-carbohydrate or ketogenic diet, during prolonged vomiting, and in people with diabetes who also take an SGLT2 inhibitor such as empagliflozin (Jardiance) or dapagliflozin (Farxiga), a class known to cause euglycemic ketoacidosis.
If you drive with an ignition interlock
This is general information, not legal advice. Interlock programs are run by states, and each has its own rules for failed tests, retests, and appeals.
Before a problem happens:
- Tell your prescriber that you have an interlock, especially before a dose increase. Ask whether a slower increase makes sense if you have had trouble eating.
- Keep eating regular meals, including some carbohydrates. Avoid starting a ketogenic diet while on an interlock.
- Keep pharmacy records and a simple log of injection dates, dose changes, and days you could barely eat or were vomiting.
- Ask your attorney or program monitor whether the program wants to know about the prescription in advance.
If you get a reading you know is wrong:
- Follow the device's retest instructions. Do not eat, drink, or use mouthwash in between, since anything in your mouth can affect the result.
- Get a blood test as soon as you can, at an urgent care clinic or emergency department. A laboratory test on blood measures ethanol, acetone, and isopropanol separately; in the 1995 Swedish case, that is how investigators showed the driver had no ethanol in his blood. Ask for ketone levels too.
- Write down what you ate in the previous day or two, your dose schedule, and any vomiting.
- Share the November 2026 case report and the 2007 ketogenic diet report with your attorney.
Get medical care right away if you have repeated vomiting, belly pain, deep or fast breathing, unusual sleepiness, or fruity-smelling breath. In the case reports above, these were signs of ketoacidosis, which can be dangerous even when blood sugar is normal.
Workplace and random breath tests
Pilots, commercial drivers, and others in safety-sensitive jobs may face random breath alcohol tests. Jones and Rössner raised this group specifically in 2007. If your job includes breath testing and you start or change a GLP-1 dose, it is reasonable to tell your employer's medical review officer or occupational health service about the prescription before a test. If a result is disputed, the same steps apply: a prompt blood test and records of what you ate and when you dosed.
What we don't know
- How often GLP-1 users reach the ketone levels needed to create a measurable amount of isopropanol in breath.
- Whether the risk differs between semaglutide, tirzepatide, and the newer pills.
- How different interlock brands respond to the small amounts of isopropanol that dieting can produce. NHTSA's model specifications test for acetone, not isopropanol.
- Whether any court or interlock program has formally accepted a GLP-1 explanation for a failed test.
GLP-1 drugs have their own link to drinking: early studies suggest they may reduce alcohol cravings. For that research, see our guide to GLP-1 drugs and alcohol use.
The bottom line
A positive interlock reading in someone on Wegovy or Zepbound is far more likely to reflect real alcohol, mouth contamination, or a device problem than a drug effect. Still, the chemistry behind a GLP-1 false positive is well documented in dieters, and the first GLP-1 case has now been published. If you take one of these drugs and must blow into a device to drive, eat enough, keep records, and get a blood test quickly if a reading doesn't match what you drank.
Limitations
- The GLP-1 evidence is a single case report whose published abstract does not include blood measurements from the time of the failed tests
- The older false-positive reports involve very low-calorie diets or ketoacidosis, which may produce more acetone than most people on GLP-1 drugs reach
- FDA adverse event reports and case reports cannot show how often ketosis or ketoacidosis occurs with GLP-1 drugs
- Interlock programs, retest rules, and appeal processes vary by state and country; this article is general information, not legal advice
- We did not find interlock manufacturers' published data on isopropanol sensitivity for specific devices
Citations
- 1. GLP-1 dose escalation and disputed ignition interlock alcohol results: Case reportpeer-reviewed Medico-Legal Journal 2026
- 2. False-positive breath-alcohol test after a ketogenic dietpeer-reviewed International Journal of Obesity 2007
- 3. Biotransformation of acetone to isopropanol observed in a motorist involved in a sobriety checkpeer-reviewed Journal of Forensic Sciences 1995
- 4. Breath-acetone concentrations in fasting healthy men: response of infrared breath-alcohol analyzerspeer-reviewed Journal of Analytical Toxicology 1987
- 5. Early Detection of Diabetic Ketoacidosis by Breathalyzer in a Sailor Reporting for Dutypeer-reviewed Military Medicine 2019
- 6. Starvation-Type Euglycemic Ketoacidosis After Unsupervised Tirzepatide Use in a Non-Obese, Non-Diabetic Womanpeer-reviewed American Journal of Case Reports 2026
- 7.
- 8. Starvation-associated high-anion gap metabolic acidosis following short-term oral semaglutide use: A case reportpeer-reviewed Journal of International Medical Research 2026
- 9.
- 10. Model Specifications for Breath Alcohol Ignition Interlock Devices (BAIIDs)government Federal Register (National Highway Traffic Safety Administration) 2013
- 11. Wegovy (semaglutide) injection and tablets: prescribing informationregulatory DailyMed
Peptides in this article
Full peptide profiles with evidence levels, dosing data, and safety notes live on peptidelist.org.
Related insights
Federal Employees and GLP-1s in 2027: Required Behavioral Therapy, Higher Costs, and How to Pay Less
Every FEHB and PSHB plan will require documented intensive behavioral therapy before and during weight-loss GLP-1 treatment in 2027, and many plans are raising member costs to 50%. A guide for federal employees, postal workers, and retirees before Open Season ends December 14.
How to Dispose of Used Ozempic, Zepbound, and Wegovy Pens, Peptide Syringes, and Needles: Sharps Rules in the U.S., UK, and Australia
New York City just raised its fine for loose needles in the trash to $250 after needle-stick injuries among sanitation workers nearly doubled. Here is what goes in a sharps container, what can go in the trash, and how to get rid of a full container where you live.
Can a GLP-1 Replace Your CPAP? Zepbound and Foundayo Cut Sleep Apnea Severity, but Most Patients Still Have the Disease After a Year
Zepbound is approved for obstructive sleep apnea, Lilly's Foundayo pill is headed to the FDA after trials published November 9, 2026, and the experimental drug retatrutide has 80-week sleep apnea results. Here is what the trials found, why most people still need their machine, what happens if you stop, and how coverage works.